Reprint of: Catestatin: A multifunctional peptide from chromogranin A (Q37802015)

23 August 2017

title

Reprint of: Catestatin: A multifunctional peptide from chromogranin A (English)

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

7 August 2024

author name string

Manjula Mahata

2

1 reference

23 August 2017

Sushil K. Mahata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20965217

7 August 2024

Maple M. Fung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20965217

7 August 2024

Daniel T. O'Connor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20965217

7 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20965217

7 August 2024

publication date

20 October 2010

1 reference

full work available at URL

23 August 2017

https://europepmc.org/articles/PMC10838673

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20965217

https://europepmc.org/articles/PMC10838673?pdf=render

7 August 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20965217

https://doi.org/10.1016/j.regpep.2010.09.007

7 August 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20965217

https://api.elsevier.com/content/article/PII:S0167011510003678?httpAccept=text/xml

7 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

https://api.elsevier.com/content/article/PII:S0167011510003678?httpAccept=text/plain

7 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

7 August 2024

1 reference

23 August 2017

volume

165

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

52-62

1 reference

The chromogranins A and B: the first 25 years and future perspectives

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The chromogranin-secretogranin family

7 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

7 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranins A and B and secretogranin II: evolutionary and functional aspects

7 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A. Storage and release in hypertension

7 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Is physiologic sympathoadrenal catecholamine release exocytotic in humans?

7 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis

7 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Biochemistry of the chromogranin A protein family

7 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The granin (chromogranin/secretogranin) family

7 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum

7 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues

7 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element

7 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

7 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism.

7 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.

7 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules

7 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments

7 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist

7 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance

7 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

An increased pool of secretory hormones and peptides in adrenal medulla of stroke-prone spontaneously hypertensive rats

7 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catecholamine storage vesicle protein expression in genetic hypertension

7 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension

7 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A in human hypertension. Influence of heredity

7 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure

7 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma

7 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones

7 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma

7 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Secretion of chromogranin A by peptide-producing endocrine neoplasms

7 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.

7 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues

7 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

7 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction

7 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function

7 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction

7 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

7 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2

7 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients.

7 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit

7 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

7 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog

7 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.

7 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism

7 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse

7 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Monocyte migration: a novel effect and signaling pathways of catestatin

7 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A

7 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury.

7 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Secretion from chromaffin cells is controlled by chromogranin A-derived peptides

7 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension

7 August 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules

7 August 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues

7 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Role of prohormone convertases in the tissue-specific processing of proglucagon

7 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Purification and characteristics of the candidate prohormone processing proteases PC2 and PC1/3 from bovine adrenal medulla chromaffin granules

7 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells

7 August 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion

7 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release

7 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin

7 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones

7 August 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion

7 August 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter.

7 August 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides

7 August 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis

7 August 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Use of isolated chromaffin cells to study basic release mechanisms

7 August 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons

7 August 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis.

7 August 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity

7 August 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A

7 August 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology

7 August 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses

7 August 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

7 August 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland

7 August 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion

7 August 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Differential secretion of catecholamines in response to peptidergic and cholinergic transmitters in rat adrenals

7 August 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Contribution of nicotinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine

7 August 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin

7 August 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Stimulus-transcription coupling in pheochromocytoma cells. Promoter region-specific activation of chromogranin a biosynthesis.

7 August 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C.

7 August 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides

7 August 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A-like immunoreactive neurites are major constituents of senile plaques

7 August 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Different chromogranin immunoreactivity between prion and a-beta amyloid plaque

7 August 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells

7 August 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin A induces a neurotoxic phenotype in brain microglial cells

7 August 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Chromogranin peptides in Alzheimer's disease

7 August 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.

7 August 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Antibacterial peptides are present in chromaffin cell secretory granules.

7 August 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes

7 August 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Plasmodium gallinaceum: differential killing of some mosquito stages of the parasite by insect defensin

7 August 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis

7 August 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom

7 August 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum

7 August 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle

7 August 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catestatin attenuates the effects of intrathecal nicotine and isoproterenol

7 August 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Cardiac endothelium and myocardial function.

7 August 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart

7 August 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Aortic Baroreceptor Activity in Normal and Hypertensive Rabbits

7 August 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

The baroreceptor-heart rate reflex in renal hypertension in the rabbit

7 August 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Diminished baroreflex sensitivity in high blood pressure

7 August 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension

7 August 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension

7 August 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

Baroreflex sensitivity and heredity in essential hypertension

7 August 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.REGPEP.2010.09.007

7 August 2024

Identifiers

1 reference

National Center for Biotechnology Information

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20965217

7 August 2024

1 reference